Arrhythmogenic cardiomyopathyGene: CDH2
Submitted on behalf of the GMS Cardiology specialist group. This gene did not achieve a consensus Green rating; however, the group agreed that the existing evidence (published and in-house data) was sufficient to support inclusion in this panel.
Created: 9 Dec 2019, 1:19 p.m. | Last Modified: 9 Dec 2019, 1:19 p.m.
Panel Version: 1.57
Submitted on behalf of the GMS Cardiology specialist group. The group has agreed that this gene should be Amber on this panel.
Created: 2 Dec 2019, 1:28 p.m. | Last Modified: 2 Dec 2019, 1:28 p.m.
Panel Version: 1.45
Comment on list classification: Was agreed by the GMS Cardiology Specialist Group that this should be Amber rating on a call on Thursday 3rd October 2019.
Created: 3 Oct 2019, 1:25 p.m. | Last Modified: 3 Oct 2019, 1:25 p.m.
Panel Version: 1.40
Source Expert Review Green was added to CDH2. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)
Gene: cdh2 has been classified as Amber List (Moderate Evidence).
Mode of inheritance for gene: CDH2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Publications for gene: CDH2 were set to
gene: CDH2 was added gene: CDH2 was added to Arrhythmogenic cardiomyopathy. Sources: Expert list Mode of inheritance for gene: CDH2 was set to Unknown